In a big shift of focus, the personal genomics company 23andMe recently announced the creation of a new therapeutics group with the intention of developing new therapies for both common and rare diseases.
Third Reported Recovery From Clinical Rabies in the U.S.
Rabies is a serious — almost always fatal — viral infection of the central nervous system. The virus is present in the saliva of infected mammals, and is most often spread via a bite wound. Raccoons, skunks, bats, foxes, and coyotes are the most common carriers of rabies in the United States, though any mammal, including domestic dogs and cats, can become infected and transmit the disease. The U.S. Centers for Disease Control and Prevention keeps statistics on rabies incidence in the U.S., and notes that cases are quite rare. Only one or two individuals a year become infected with the rabies virus, and prophylaxis (vaccination post-exposure, but prior to the development of symptoms) is almost always effective.
Genetic Risk Factor for Peanut Allergies Identified
It is difficult to find a school, camp or other facility catering to children these days that is not nut free. The prevalence of peanut allergies in preschool and school age children in the UK, the US and Canada is between 1.2 – 1.6%, which is about twice the rate at which it occurs in adults in these countries. Nut allergies, especially peanut allergies, are scary. And although they have been on the rise, no one really knows why. Researchers in Scotland recently reported in The Journal of Allergy and Clinical Immunology that mutations in the gene for filaggrin, a protein found in skin, are a “significant risk factor for peanut allergy” [1].